Medtronic received information that during the implant of this transcatheter bioprosthetic valve, it was difficult to restore the patient's blood pressure following the pre-implant balloon aortic valvuloplasty (bav).Prior to the implant, the patient had hypocardiac function with an ejection fraction of 30-39%.Ventricular tachycardia occurred twice during the procedure and age-related macular degeneration (amd) was administered and external shock (dc) were performed.After the pressure increased, the delivery catheter system (dcs) was advanced passed the aortic valve, however when crossing, the patient's blood pressure decreased again.The valve was deployed to two thirds, however the patient's pressure did not recover.The valve was recaptured so percutaneous cardiopulmonary support (pcps) could be used.The blood pressure became stable and the valve implant was completed.The patient was attempted to be removed from pcps, however the blood pressure dropped so an intra-aortic balloon pumping (iabp) was used.The patient was transferred to the intensive care unit (icu).Three days following the valve implant, the ibap was removed.Twenty two days following the valve implant the cardiopulmonary arrest occurred and resuscitation efforts were performed.Twenty three days following the valve implant, the patient died.The cause of death was unknown.It was reported that the patient had general weakness due to low cardiac function, an unknown fever and possibility that the cause may have been from aspiration and choking of the feeding tube.It is unknown whether an autopsy was performed.
|